Endocannabinoids: getting the message across.
paper
Cited
Public
Unavailable
- Authors
- Alger, Bradley E
- Year
- 2004
- Journal
- Proceedings of the National Academy of Sciences of the United States of America
- PMID
- 15173576
- DOI
- 10.1073/pnas.0402935101
- PMCID
- PMC423223
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans. | 2019 | 31740666 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Chronic orofacial pain and pharmacological management: a clinical guide. | Guan G et al. | — | 2025 | → |
| Mechanistic interplay of different mediators involved in mediating the anti-depressant effect of isoflavones. | Diksha et al. | — | 2024 | → |
| Myogenic Classical Endocannabinoids, Their Targets and Activity. | Balezina OP et al. | — | 2024 | → |
| Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles. | Sionov RV et al. | — | 2022 | → |
| Sex-specific and social experience-dependent oxytocin-endocannabinoid interactions in the nucleus accumbens: implications for social behaviour. | Borie AM et al. | — | 2022 | → |
| Tetracosahexaenoylethanolamide, a novel <i>N</i>-acylethanolamide, is elevated in ischemia and increases neuronal output. | Lin L et al. | — | 2020 | → |
| A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans. | Cheng Z et al. | — | 2019 | → |
| Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter. | Di Scala C et al. | — | 2018 | → |
| Selective Role of RGS9-2 in Regulating Retrograde Synaptic Signaling of Indirect Pathway Medium Spiny Neurons in Dorsal Striatum. | Song C et al. | — | 2018 | → |
| N-Acylethanolamines: lipid metabolites with functions in plant growth and development. | Blancaflor EB et al. | — | 2014 | → |
| Cortical basket cell dysfunction in schizophrenia. | Curley AA et al. | — | 2012 | → |
| Endocannabinoid system dysfunction in mood and related disorders. | Ashton CH et al. | — | 2011 | → |
| Local network regulation of orexin neurons in the lateral hypothalamus. | Burt J et al. | — | 2011 | → |
| Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. | Zanelati TV et al. | — | 2010 | → |
| Inhibitory neurons hear themselves during development. | Owen SF et al. | — | 2010 | → |
| Altered GABAergic neurotransmission is associated with increased kainate-induced seizure in prostaglandin-endoperoxide synthase-2 deficient mice. | Toscano CD et al. | — | 2008 | → |
| A potential function of endocannabinoids in the selection of a navigation strategy by rats. | Rueda-Orozco PE et al. | — | 2008 | → |
| Neuroendocrine control of food intake. | Valassi E et al. | — | 2008 | → |
| [Neuropsychopharmacology of delta-9-tetrahydrocannabinol]. | Costentin J | — | 2008 | → |
| Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells. | Jiang S et al. | — | 2007 | → |
| Rimonabant: a novel selective cannabinoid-1 receptor antagonist for treatment of obesity. | Patel PN et al. | — | 2007 | → |
| Anxiolytic-like properties of the anandamide transport inhibitor AM404. | Bortolato M et al. | — | 2006 | → |
| Effect of an unstirred layer on the membrane permeability of anandamide. | Bojesen IN et al. | — | 2006 | → |
| Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors. | Petersen G et al. | — | 2006 | → |
| PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons. | Sang N et al. | — | 2006 | → |
| Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. | Ashton CH et al. | — | 2005 | → |
| Rimonabant--a selective CB1 antagonist. | Boyd ST et al. | — | 2005 | → |